🇺🇸 FDA
Patent

US 7544499

Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof

granted A61KA61K38/47

Quick answer

US patent 7544499 (Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof) held by HALOZYME, INC. expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/47